A major breakthrough in cancer research is arising with the use of mini-antibodies to re-engage dysfunctional p53. This essential cancer suppressor protein is frequently disabled in several kinds of tumors, causing https://thegreatbookmark.com/story21957329/nanobodies-reactivate-tumor-suppressor-p53-the-promising-pathway-for-cancer-therapy